Page 40 - 75_02
P. 40

ANTONIO FERRER MONTIEL  AN. R. ACAD. NAC. FARM.

 3. Peters, E. M., Ericson, M. E., Hosoi, J., Seiffert, K., Hordinsky, M. K., Ansel,
       J. C., Paus, R. & Scholzen, T. E. (2006) Neuropeptide control mechanisms in
       cutaneous biology: physiological and clinical significance. J. Invest. Dermatol.
       126: 1937-1947.

 4. Fuhlbrigge, R. C. & Weishaupt, C. (2007) Adhesion molecules in cutaneous
       immunity. Semin. Immunopathol. 29: 45-57.

 5. Joachim, R. A., Kuhlmei, A., Dinh, Q. T., Handjiski, B., Fischer, T., Peters, E.
       M., Klapp, B. F., Paus, R. & Arck, P. C. (2007) Neuronal plasticity of the
       «brain-skin connection»: stress-triggered up-regulation of neuropeptides in
       dorsal root ganglia and skin via nerve growth factor-dependent pathways.
       J. Mol. Med. 85: 1369-1378.

 6. Cao, Y. Q., Mantyh, P. W., Carlson, E. J., Gillespie, A. M., Epstein, C. J. &
       Basbaum, A. I. (1998) Primary afferent tachykinins are required to experience
       moderate to intense pain. Nature. 392: 390-394.

 7. Bhatia, M., Slavin, J., Cao, Y., Basbaum, A. I. & Neoptolemos, J. P. (2003)
       Preprotachykinin-A gene deletion protects mice against acute pancreatitis and
       associated lung injury. Am. J Physiol Gastrointest. Liver Physiol. 284: G830-
       G836.

 8. Salmon, A. M., Damaj, M. I., Marubio, L. M., Epping-Jordan, M. P., Merlo-
       Pich, E. & Changeux, J. P. (2001) Altered neuroadaptation in opiate dependen-
       ce and neurogenic inflammatory nociception in alpha CGRP-deficient mice.
       Nat. Neurosci. 4: 357-358.

 9. Messeguer, A., Planells-Cases, R. & Ferrer-Montiel, A. (2006) Physiology and
       pharmacology of the vanilloid receptor. Curr. Neuropharmacol. 4: 1-15.

10. Planells-Cases, R., García-Sanz, N., Morenilla-Palao, C. & Ferrer-Montiel, A.
       (2005) Functional aspects and mechanisms of TRPV1 involvement in neu-
       rogenic inflammation that leads to thermal hyperalgesia. Pflugers Arch. 451:
       151-159.

11. Szallasi, A. & Appendino, G. (2004) Vanilloid receptor TRPV1 antagonists as
       the next generation of painkillers. Are we putting the cart before the horse?
       J. Med. Chem. 47: 2717-2723.

12. Lynn, B. (1990) Capsaicin: actions on nociceptive C-fibres and therapeutic
       potential. Pain. 41: 61-69.

13. Montell, C. & Caterina, M. J. (2007) Thermoregulation: channels that are cool
       to the core, Curr. Biol. 17: R885-R887.

14. Caterina, M. J. (2007) Transient receptor potential ion channels as partici-
       pants in thermosensation and thermoregulation. Am. J. Physiol. Regul. Integr.
       Comp. Physiol. 292: R64-R76.

15. Szallasi, A., Cortright, D. N., Blum, C. A. & Eid, S. R. (2007) The vanilloid
       receptor TRPV1: 10 years from channel cloning to antagonist proof-of-con-
       cept. Nat. Rev. Drug Discov. 6: 357-372.

16. Di, M., V, Gobbi, G. & Szallasi, A. (2008) Brain TRPV1: a depressing TR(i)P
       down memory lane? Trends Pharmacol. Sci.

17. Toth, B. I., Geczy, T., Griger, Z., Dozsa, A., Seltmann, H., Kovacs, L., Nagy,
       L., Zouboulis, C. C., Paus, R. & Biro, T. (2008) Transient Receptor Potential

270
   35   36   37   38   39   40   41   42   43   44   45